Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers
Completed · Phase 2 · NCT05041257
Conditions: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
At a glance
- Research payments reported, 2025
- $151,554
- U.S. investigators named
- 10
- Sites paid
- 9
- Planned or actual enrollment
- 79
About the trial
- Sponsor
- AbbVie
- Tested
- Mirvetuximab soravtansine (drug)
- Dates
- Started 2021-10-19; completion 2024-12-12
- Results posted
- Yes
PICCOLO (IMGN853-0419) is a Phase 2 multicenter, open label study designed to evaluate the safety and efficacy of Mirvetuximab Soravtansine in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
From ClinicalTrials.gov, last updated 2026-01-09. Full record, eligibility and contacts (opens in a new tab)
Industry funding
AbbVie Inc. reported $151,554 in research payments for this study in 2025 (21 payments).
Products named: Elahere
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Gottfried E. Konecny, MD Hematology & Oncology · Los Angeles, CA
- Bradley R. Corr, MD Gynecologic Oncology · Aurora, CO
- Viralkumar K. Bhanderi, M.D. Medical Oncology · Tallahassee, FL
- Patricia S. Braly, MD Gynecologic Oncology · Covington, LA
- Sharyn N. Lewin, M.D. Gynecologic Oncology · Teaneck, NJ
- Peter G. Rose, MD Gynecologic Oncology · Cleveland, OH
- Emily Whitman-purves, M.D. Hematology & Oncology · Columbus, OH
- Cara A. Mathews, MD OB-GYN (Obstetrics & Gynecology) · Providence, RI
- Erika P. Hamilton, M.D. Hematology & Oncology · Nashville, TN
- Ying Zhuo, M.D. Hematology & Oncology · Kennewick, WA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- City of Hope National Medical Ctr $65,090
- Sarah Cannon Research Institute LLC $34,029
- Women & Infants Hospital of Rhode Island, RI $14,317
- Regents of the University of Colorado $9,523
- Kadlec Regional Medical Center, WA $7,275
- Cleveland Clinic, OH $7,238
- Patricia Braly MD Apmc $6,181
- Holy Name Medical Center $4,000
- Ronald Reagan UCLA Medical Center, CA $3,901
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.